HeMemics Type C Meeting with FDA Blood Applications Division
HeMemics to meet with the FDA to discuss which of the available paths that HeMemics Platelet Additive Solution (HemSol™) may take in pursuit of FDA approval and commercialization - February 15, 2014
HeMemics Announces Election of Larry Simpson to Its Board of Directors
Election of Larry Simpson to HeMemics Board of Directors - February 15, 2014
Press Releases 1 - 2 of 2